In waiting for a retestAre you interrested in buying NASDAQ:VRTX ? I'm looking for a break confirmation of the 2-years trendline to evaluate a first entry in the 370s. Then the POC line could be a valid support to regain the trend.
14.04USD
3.62 BUSD
9.84 BUSD
257.54 M
About Vertex Pharmaceuticals Incorporated
Sector
CEO
Reshma Kewalramani
Headquarters
Boston
Website
Employees (FY)
5.4 K
Founded
1989
ISIN
US92532F1003
FIGI
BBG000C1S2X2
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
VRTX Stock – the Alternative to OxyContin?In the wake of the opiod epidemic, brought on in part by the success of Oxycodone, a new exceptional drug is being developed by Vertex Pharmaceuticals (NASDAQ: VRTX). With the intention of providing relief from severe pain without the addictive properties of opioids, Vertex’s new drug could be on tr
temporary pain for long term gainsAs price action is currently receiving short term bearishness from sellers from being near all time highs, accumulation of shares are lessening however the uptrend has been strong overall. Look for more of a pullback leading into earnings and with strong support should provide another entry long in
Stock of the Month: Vertex (VRTX)Our portfolio is up by more than 15% in the month of November. We are strictly following Mark Minervini's Trading Methodology. Here is a quick summary:
Mark Minervini's trading methodology, often encapsulated in his SEPA (Specific Entry Point Analysis) system, is a comprehensive approach to trading
Vertex’s Stock Heads for All-Time HighVertex Pharmaceuticals Inc. shares were on track for an all-time high Wednesday after the company released new data from a trial of its investigational non-opioid pain medicine.
The stock jumped more than 10% Wednesday morning, on pace for its largest percentage gain in more than three years, and w
Vertex Pharmaceuticals: Riding the Bullish Wave with a Bull Put In the world of trading, there are a variety of strategies that investors can employ to maximize their returns. One such strategy that has gained popularity in recent years is the vertical spread bull put. This strategy involves buying a put option with a lower strike price and selling a put option
VRTX shortHi traders,
let's have a look at VRTX analysis on daily timeframe.
The support at 342$ has been retested many times however, this time we are expecting support to fail.
If horizontal support fails and the price breaks upslopping support (blue line), it will look more bearish and short position ca
Trading Idea: Buy Vertex Pharmaceuticals (VRTX) StockVertex Pharmaceuticals (VRTX) has experienced a decline of around 5.84% in its share price over the past month. However, based on the provided facts, it appears that Vertex Pharmaceuticals is in a strong financial position and could be a good investment opportunity.
Here is the core logic behind th
VRTX: opened a new 10% positionWe have added a new position and here is a link to the updated portfolio:
www.tradingview.com
VRTX had a positive earnings surprise on Nov 6th which pushed the price up to new highs. These new highs have been followed by a natural pullback which occured under low trading volume.
The new position
Vertex at its VertexThe 1-2-3-4-5 Impulse Wave (blue wave) formation on VRTX is nearly complete. We can see a rising wedge (white colour) after impulse wave 3. This is impulse wave 5, which can be in the form of a wedge. VRTX is consolidating at the top. It may make one last effort to reach the top, form a double top a
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where VRTX is featured.
Frequently Asked Questions
The current price of VRTX is 393.48 USD — it has increased by 0.10% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Vertex Pharmaceuticals Incorporated stocks are traded under the ticker VRTX.
Vertex Pharmaceuticals Incorporated is going to release the next earnings report on May 6, 2024. Keep track of upcoming events with our Earnings Calendar.
VRTX stock is 1.31% volatile and has beta coefficient of 0.94. Check out the list of the most volatile stocks — is Vertex Pharmaceuticals Incorporated there?
One year price forecast for Vertex Pharmaceuticals Incorporated has a max estimate of 574.00 USD and a min estimate of 325.00 USD.
VRTX earnings for the last quarter are 4.08 USD whereas the estimation was 3.93 USD which accounts for 3.72% surprise. Estimated earnings for the next quarter are 4.07 USD. See more details about Vertex Pharmaceuticals Incorporated earnings.
Vertex Pharmaceuticals Incorporated revenue for the last quarter amounts to 2.48 B USD despite the estimated figure of 2.50 B USD. In the next quarter revenue is expected to reach 2.51 B USD.
Yes, you can track Vertex Pharmaceuticals Incorporated financials in yearly and quarterly reports right on TradingView.
VRTX stock has fallen by 2.68% compared to the previous week, the month change is a 4.61% fall, over the last year Vertex Pharmaceuticals Incorporated has showed a 20.41% increase.
VRTX net income for the last quarter is 968.80 M USD, while the quarter before that showed 1.04 B USD of net income which accounts for −6.42% change. Track more Vertex Pharmaceuticals Incorporated financial stats to get the full picture.
Today Vertex Pharmaceuticals Incorporated has the market capitalization of 101.64 B, it has decreased by 1.27% over the last week.
No, VRTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vertex Pharmaceuticals Incorporated stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 5.40 K employees. See our rating of the largest employees — is Vertex Pharmaceuticals Incorporated on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vertex Pharmaceuticals Incorporated technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vertex Pharmaceuticals Incorporated stock shows the buy signal. See more of Vertex Pharmaceuticals Incorporated technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Vertex Pharmaceuticals Incorporated future price: according to them, VRTX price has a max estimate of 574.00 USD and a min estimate of 325.00 USD. Read a more detailed Vertex Pharmaceuticals Incorporated forecast: see what analysts think of Vertex Pharmaceuticals Incorporated and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Vertex Pharmaceuticals Incorporated EBITDA is 3.95 B USD, and current EBITDA margin is 45.32%. See more stats in Vertex Pharmaceuticals Incorporated financial statements.